Bath Savings Trust Co lessened its stake in shares of Balchem Co. (NASDAQ:BCPC) by 1.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 58,685 shares of the basic materials company’s stock after selling 775 shares during the quarter. Bath Savings Trust Co owned about 0.18% of Balchem worth $5,446,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of the company. Advisor Group Inc. lifted its position in shares of Balchem by 5.5% during the 4th quarter. Advisor Group Inc. now owns 2,470 shares of the basic materials company’s stock worth $195,000 after buying an additional 128 shares during the last quarter. CIBC Asset Management Inc lifted its position in shares of Balchem by 7.3% during the 4th quarter. CIBC Asset Management Inc now owns 2,619 shares of the basic materials company’s stock worth $205,000 after buying an additional 178 shares during the last quarter. Stephens Inc. AR lifted its position in shares of Balchem by 5.9% during the 4th quarter. Stephens Inc. AR now owns 3,437 shares of the basic materials company’s stock worth $269,000 after buying an additional 192 shares during the last quarter. State of Alaska Department of Revenue lifted its position in shares of Balchem by 2.0% during the 4th quarter. State of Alaska Department of Revenue now owns 10,784 shares of the basic materials company’s stock worth $844,000 after buying an additional 210 shares during the last quarter. Finally, Bank of Montreal Can lifted its position in shares of Balchem by 13.6% during the 4th quarter. Bank of Montreal Can now owns 1,926 shares of the basic materials company’s stock worth $151,000 after buying an additional 231 shares during the last quarter. Institutional investors and hedge funds own 87.80% of the company’s stock.
Shares of Balchem stock opened at $99.13 on Thursday. The firm has a market capitalization of $3.20 billion, a PE ratio of 32.93 and a beta of 1.00. Balchem Co. has a 12 month low of $73.16 and a 12 month high of $117.79. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.94 and a current ratio of 2.76.
Several analysts have recently weighed in on BCPC shares. HC Wainwright set a $101.00 price objective on shares of Balchem and gave the stock a “buy” rating in a research report on Tuesday, February 5th. Zacks Investment Research cut shares of Balchem from a “buy” rating to a “hold” rating in a report on Monday, February 18th. Seaport Global Securities began coverage on shares of Balchem in a report on Thursday, February 21st. They issued a “neutral” rating on the stock. Finally, BidaskClub raised shares of Balchem from a “sell” rating to a “hold” rating in a report on Wednesday, February 20th. One analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $105.50.
ILLEGAL ACTIVITY WARNING: This story was posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at https://www.baseballdailydigest.com/news/2019/04/25/bath-savings-trust-co-decreases-position-in-balchem-co-bcpc.html.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.